NEW YORK (GenomeWeb News) — Affymetrix today reported that revenue for the third quarter increased around 1 percent as last year's profit swung to a loss.
Total receipts for the three months ended Sept. 30 inched up to $84.6 million from $83.4 million year over year
Affy said $59.8 million in revenue during the period came from GeneChip sales while about $10.1 million was made on reagent revenue and $7.7 million from its genotyping services.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Sponsored by

This webinar will present a method for RNA-seq expression analysis of FFPE-derived RNA samples that are too degraded for successful application of standard RNA-seq techniques.

Sponsored by

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.